It’s not unusual these days to hear chatter about R&D layoffs, with biotechs of all stripes cutting back and carving out longer runways through cost reductions. But buzz about a burst of Bristol Myers Squibb resumes hitting the market out of New Jersey drew some special attention.
I queried a...
